AMF Medical
Ecublens
About AMF Medical
AMF Medical is using proprietary breakthrough technologies and world-class user-experience design to develop Sigi, a novel patch pump to administer insulin, with unparalleled ease of use and ready for seamless integration into closed loop systems, with 3rd party Continuous Glucose Monitoring products and dose-calculating algorithms. The vision is to reduce therapy “burden” and offer a simple, better life for people with diabetes. In early 2021, AMF Medical SA was separated from Advanced Microfluidics SA, which – using related technologies - develops, manufactures, and commercializes high-end lab equipment components.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $21.0M
- Funding stage: M&A
- Last round: Corporate Round (Sep 2022)
- Website: sigipump.com
- Phone: 41 21 552 3670
Industries & Categories
Diabetes, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/amf-medical-100897 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.